“…M100907 also reduces the elevated locomotor activity (Gleason and Shannon, 1997;Martin et al, 1997), forced swim immobility (Corbett et al, 1999), and deficit in prepulse inhibition (Varty et al, 1999) induced by NMDA receptor antagonists. In rats performing a 5-CSRT task, M100907 improved attentional performance (Winstanley et al, 2003;Passetti et al, 2003a) and reversed the deficit in inhibitory response control induced by systemic administration of the NMDA receptor antagonists, dizocilpine and Ro 63-1908 (Higgins et al, 2004).…”